Nivalis Therapeutics (NVLS) Stock: Here’s What You Need To Know

Nivalis Therapeutics (NASDAQ:NVLS) On Monday Nivalis Therapeutics stock fell by more than 52% after the company announced that it had failed its phase 2 trial in patients with Cystic Fibrosis — CF. As soon as the results were released the stock tumbled as investors sold their shares to the open market. The phase 2 trial … Read more

Raptor Pharmaceuticals (RPTP) Stock Bought Out: Here’s What You Need To Know

Raptor Pharmaceuticals (NASDAQ:RPTP) On Monday, Horizon Pharma bought out Raptor Pharmaceuticals for $800 million ┬áin an all cash deal. Taking into account the amount of cash in the buyout, it translates to $9 per share. Although the stock traded higher by 20.3% to $8.96. Before the news of the announcement Raptor’s stock traded at $7.45 … Read more

Biotech Stock News (KBIO) (SNY) (CLVS) (AZN) (VRTX)

KaloBios Pharmaceuticals (NASDAQ:KBIO) Last week I wrote how Kalobios was winding down its operations and was looking to put itself up for sale. In an unforeseen event, Martin Shkreli took a big investment in the company sending the share price higher. Before I go any further let me provide a little backstory so that everyone … Read more

Why Gilead Sciences Should Buy Out Achillion Pharmaceuticals

Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN) | Gilead Sciences, Inc. (NASDAQ: GILD) Yesterday, major rumors started to fly around in market talk that Gilead Sciences was planning on acquiring Gilead Sciences. The rumors started because both ACHN and GILD were believed to have missed the UBS conference scheduled yesterday. While some may be pointing to the … Read more

Gilead (GILD) | Would Buying Vertex (VRTX) Be A Good Idea?

Gilead Sciences, Inc. (NASDAQ: GILD) Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) There’s a big rumor that started circulating outlets recently revolving around the idea that Gilead Sciences may move to acquire Vertex Pharmaceuticals. With so much buzz around the topic, I had to do a bit of my own research to see if the acquisition made … Read more